Medication Competition Act
The bill requires HHS to determine and publish exclusivity periods for first interchangeable biologics and reference products to increase transparency and predictability in biosimi
The bill requires HHS to determine and publish exclusivity periods for first interchangeable biologics and reference products to increase transparency and predictability in biosimi
WeVote — Public opinion
No community votes yet. Be the first to weigh in from the Vote tab.
Versions
Bill text & amendments
The official bill text and any amendments will be posted here once available.